Rowland Perkins - 21 Jul 2023 Form 4 Insider Report for OCULUS VISIONTECH INC. (OVTZ)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Jul 2023, 15:06:13 UTC
Prior SEC filing
19 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rowland Perkins

Key filing fact

Rowland Perkins filed Form 4 for OCULUS VISIONTECH INC. (OVTZ) on 21 Jul 2023.

Key facts

  • This page summarizes Rowland Perkins's Form 4 filing for OCULUS VISIONTECH INC. (OVTZ).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 21 Jul 2023, 15:06.

Change

  • Previous filing in this sequence was filed on 19 Jan 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OVTZ transaction Derivative

Stock Options

Disposed to Issuer

Transaction value
$0
Shares
-210,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
21 Jul 2020
Ownership
Direct
Underlying class
Common stock
Underlying amount
210,000
Exercise price
$0.2603
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The exercise price reported above was converted from the Canadian exercise price of C$0.35 using an exchange rate of C$1.34460=US$1.00

Footnote F2

Options were granted on July 21, 2020 and vested as follows: 20% on January 21, 2021, 20% on July 21, 2021, 20% on January 21, 2022, 20% on July 21, 2022 and 20% on January 21, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .